What do CROs and Sponsor consider when selecting a site? Within the pharmaceutical industry, 45% of clinical trials are completed late, or 70%-80% of studies are delayed or do not meet their timelines. Due to these reasons, one of the [...]

Chemists’ breakthrough in synthesis advances a potent anti-cancer agent It’s a feat three decades in the making: Harvard University chemists have achieved what a new paper calls a “landmark in drug discovery” with the total synthesis of halichondrin. Known to [...]

New Vulnerability Found in Major Human Viruses Discovery of a new feature of a large class of pathogenic viruses may allow development of new antiviral medications for the common cold, polio and other illnesses, according to a new study publishing [...]

ASCO 2019: Delays Lead to Late-Stage Diagnosis of Young People With Colorectal Cancer The incidence of early onset colorectal cancer has increased by nearly 50 percent in the last 30 years. A University of Colorado Cancer Center study presented at [...]

Novel Vaccine for colorectal cancer Shows Positive Phase I Results A new colorectal cancer vaccine showed positive results in phase 1 clinical trial to demonstrate that the approach is safe. The patients treated had no signs of serious adverse events [...]

Novel Therapies Slow CKD Progression in Patients With Diabetes   Treatment options for patients with CKD are limited and often determined by the etiology of the CKD. RAAS blockade (ACE inhibitors or angiotensin receptor blockers) has so far been the [...]

A Tiny Cry for Help From Inside the Liver Could Lead to Better Treatment But when something comes along that badly injures enough of those cells—such as a liver-damaging overdose of pain medicine—this vital work can come to a screeching [...]

What lifestyle and environmental factors may be involved with infertility in females and males? Research consistently shows that lifestyle factors—what you eat, how well you sleep, where you live, and other behaviors—have profound effects on health and disease. Fertility is [...]